ARCHIVES

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

This article is from The Cancer Letter archive.

Vol. 07 No. 45 | November 6, 1981

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Should Be Trimmed, Brought Under Control Of DCT, Surgical Panel Suggests

May 31, 1974

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

In Brief: DCPC Still Looking For Yates’ Replacement New jersey Commission Offers New Fellowships

December 4, 1987

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

NCI Cooperative Group Clinical Trials Approved

August 27, 2010

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010